{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T13:37:13Z","timestamp":1782135433637,"version":"3.54.5"},"reference-count":45,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diabetes & Metabolic Syndrome: Clinical Research & Reviews"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1016\/j.dsx.2021.102355","type":"journal-article","created":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T12:10:45Z","timestamp":1638360645000},"page":"102355","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Plasma homocysteine is associated with nonproliferative retinopathy in patients with type 2 diabetes without renal disease"],"prefix":"10.1016","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7535-3631","authenticated-orcid":false,"given":"Martina","family":"Tomi\u0107","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Romano","family":"Vrabec","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Spomenka","family":"Ljubi\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomislav","family":"Bulum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2901-0646","authenticated-orcid":false,"given":"Dario","family":"Raheli\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.dsx.2021.102355_bib1","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1056\/NEJM199104253241701","article-title":"Hyperhomocysteinaemia: an independent risk factor for vascular disease","volume":"324","author":"Clarke","year":"1991","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.dsx.2021.102355_bib2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1182\/blood.V90.1.1","article-title":"Homocysteine and thrombotic disease","volume":"90","author":"D'Angelo","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.dsx.2021.102355_bib3","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/S0002-9394(14)70800-1","article-title":"Retinal vein occlusion and transient monocular visual loss associated with hyperhomocysteinaemia","volume":"124","author":"Biousse","year":"1997","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.dsx.2021.102355_bib4","first-page":"226","article-title":"Homocysteine concentrations in patients with diabetes mellitus-relationship to microvascular and macrovascular disease","volume":"18","author":"Elias","year":"2008","journal-title":"Eur J Ophthalmol"},{"key":"10.1016\/j.dsx.2021.102355_bib5","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1038\/sj.eye.6700702","article-title":"Hyperhomocysteinemia in patients with diabetes mellitus with and without diabetic retinopathy","volume":"18","author":"Goldstein","year":"2004","journal-title":"Eye"},{"key":"10.1016\/j.dsx.2021.102355_bib6","doi-asserted-by":"crossref","first-page":"2693","DOI":"10.1001\/jama.1993.03510220049033","article-title":"Vitamin status and intake as primary determinates of homocysteinemia in an elderly population","volume":"270","author":"Selhub","year":"1993","journal-title":"J\u00a0Am Med Assoc"},{"key":"10.1016\/j.dsx.2021.102355_bib7","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1055\/s-2000-8407","article-title":"Homocysteine and renal disease","volume":"26","author":"Van Guldener","year":"2000","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.dsx.2021.102355_bib8","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1111\/j.1365-2796.2005.01560.x","article-title":"Plasma homocysteine and microvascular and macrovascular complications in type 1 diabetes: a cross-sectional nested case-control study","volume":"258","author":"Soedamah-Muthu","year":"2005","journal-title":"J\u00a0Intern Med"},{"key":"10.1016\/j.dsx.2021.102355_bib9","first-page":"571","article-title":"Homocysteine, cysteine, folate and vitamin B\u2081\u2082 status in type 2 diabetic patients with chronic kidney disease","volume":"28","author":"Pastore","year":"2015","journal-title":"J\u00a0Nephrol"},{"key":"10.1016\/j.dsx.2021.102355_bib10","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1373\/clinchem.2004.044453","article-title":"Disturbed homocysteine and methionine cycle intermediates S-adenosylhomocysteine and S-adenosylmethionine are related to degree of renal insufficiency in type 2 diabetes","volume":"51","author":"Herrmann","year":"2005","journal-title":"Clin Chem"},{"key":"10.1016\/j.dsx.2021.102355_bib11","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1007\/s001250050969","article-title":"Plasma homocysteine is related to albumin excretion rate in patients with diabetes mellitus: a new link between diabetic nephropathy and cardiovascular disease?","volume":"41","author":"Chico","year":"1998","journal-title":"Diabetologia"},{"key":"10.1016\/j.dsx.2021.102355_bib12","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/S0140-6736(09)62124-3","article-title":"Diabetic retinopathy","volume":"376","author":"Cheung","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.dsx.2021.102355_bib13","first-page":"121","article-title":"Homocysteine: a potential biomarker for diabetic retinopathy","volume":"8","author":"Tawfik","year":"2019","journal-title":"J\u00a0Clin Med"},{"key":"10.1016\/j.dsx.2021.102355_bib14","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/s13098-018-0362-1","article-title":"Association between homocysteine level and the risk of diabetic retinopathy: a systematic review and meta-analysis","volume":"10","author":"Lei","year":"2018","journal-title":"Diabetol Metab Syndrome"},{"key":"10.1016\/j.dsx.2021.102355_bib15","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1001\/archophthalmol.2012.1800","article-title":"Retinopathy and chronic kidney disease in the chronic renal insufficiency cohort (CRIC) study","volume":"130","author":"Grunwald","year":"2012","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.dsx.2021.102355_bib16","doi-asserted-by":"crossref","first-page":"50","DOI":"10.2337\/dc07-0632","article-title":"Homocysteine and diabetic retinopathy","volume":"31","author":"Brazionis","year":"2008","journal-title":"Diabetes Care"},{"key":"10.1016\/j.dsx.2021.102355_bib17","doi-asserted-by":"crossref","first-page":"595","DOI":"10.4093\/dmj.2011.35.6.595","article-title":"The Relationship among homocysteine, bilirubin, and diabetic retinopathy","volume":"35","author":"Cho","year":"2011","journal-title":"Diabetes Metab J"},{"key":"10.1016\/j.dsx.2021.102355_bib18","doi-asserted-by":"crossref","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","article-title":"A\u00a0new equation to estimate glomerular filtration rate","volume":"150","author":"Levey","year":"2009","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.dsx.2021.102355_bib19","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1016\/j.clinbiochem.2012.07.115","article-title":"Estimating glomerular filtration rate (GFR) in diabetes: the performance of MDRD and CKD-EPI equations in patients with various degrees of albuminuria","volume":"45","author":"Vu\u010di\u0107 Lovren\u010di\u0107","year":"2012","journal-title":"Clin Biochem"},{"key":"10.1016\/j.dsx.2021.102355_bib20","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1007\/BF00410281","article-title":"Methodology for retinal photography and assessment of diabetic retinopathy: the EURODIAB IDDM Complications Study","volume":"38","author":"Aldington","year":"1995","journal-title":"Diabetologia"},{"key":"10.1016\/j.dsx.2021.102355_bib21","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/s005920200033","article-title":"Associations of plasma homocysteine concentration in subjects with type 2 diabetes mellitus","volume":"39","author":"Abdella","year":"2002","journal-title":"Acta Diabetol"},{"key":"10.1016\/j.dsx.2021.102355_bib22","doi-asserted-by":"crossref","first-page":"637","DOI":"10.3109\/00365519409087544","article-title":"Lack of association between plasma homocysteine levels and microangiopathy in type 1 diabetes mellitus","volume":"548","author":"Agardh","year":"1994","journal-title":"Scand J Clin Lab Invest"},{"key":"10.1016\/j.dsx.2021.102355_bib23","doi-asserted-by":"crossref","first-page":"191497","DOI":"10.1155\/2014\/191497","article-title":"Homocysteine serum levels in diabetic patients with nonproliferative, proliferative and without retinopathy","volume":"2014","author":"Malaguarnera","year":"2014","journal-title":"BioMed Res Int"},{"key":"10.1016\/j.dsx.2021.102355_bib24","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1186\/s13000-014-0167-y","article-title":"Relationship between homocysteine level and diabetic retinopathy: a systematic review and meta-analysis","volume":"9","author":"Xu","year":"2014","journal-title":"Diagn Pathol"},{"key":"10.1016\/j.dsx.2021.102355_bib25","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0026747","article-title":"Status of B-vitamins and homocysteine in diabetic retinopathy: association with vitamin-B12 deficiency and hyperhomocysteinemia","volume":"6","author":"Satyanarayana","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.dsx.2021.102355_bib26","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1111\/j.1753-4887.1994.tb01369.x","article-title":"Vitamin nutrition status and homocysteine: an atherogenic risk factor","volume":"52","author":"Ubbink","year":"1994","journal-title":"Nutr Rev"},{"key":"10.1016\/j.dsx.2021.102355_bib27","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.2147\/OPTH.S77538","article-title":"Folate status in type 2 diabetic patients with and without retinopathy","volume":"9","author":"Malaguarnera","year":"2015","journal-title":"Clin Ophthalmol"},{"key":"10.1016\/j.dsx.2021.102355_bib28","doi-asserted-by":"crossref","first-page":"50","DOI":"10.2337\/dc07-0632","article-title":"Homocysteine and diabetic retinopathy","volume":"31","author":"Brazionis","year":"2008","journal-title":"Diabetes Care"},{"key":"10.1016\/j.dsx.2021.102355_bib29","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/s12020-009-9218-7","article-title":"Methyltetrahydrofolate reductase C677T gene mutation and hyperhomocysteinemia as a novel risk factor for diabetic nephropathy","volume":"36","author":"Ukinc","year":"2009","journal-title":"Endocrine"},{"key":"10.1016\/j.dsx.2021.102355_bib30","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1016\/j.ophtha.2009.02.033","article-title":"Homocysteine, methylenetetrahydrofolate reductase C677T polymorphism, and risk of retinal vein occlusion: a meta-analysis","volume":"116","author":"McGimpsey","year":"2009","journal-title":"Ophthalmology"},{"key":"10.1016\/j.dsx.2021.102355_bib31","doi-asserted-by":"crossref","first-page":"185","DOI":"10.4158\/EP11147.OR","article-title":"Vitamin D insufficiency in diabetic retinopathy","volume":"18","author":"Payne","year":"2012","journal-title":"Endocr Pract"},{"key":"10.1016\/j.dsx.2021.102355_bib32","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1056\/NEJMra1909637","article-title":"Evaluation and care of patients with diabetic retinopathy","volume":"382","author":"Jampol","year":"2020","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.dsx.2021.102355_bib33","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1006\/jsre.2001.6304","article-title":"Homocysteine decreases endothelium-dependent vasorelaxation in porcine arteries","volume":"102","author":"Chen","year":"2002","journal-title":"J\u00a0Surg Res"},{"key":"10.1016\/j.dsx.2021.102355_bib34","doi-asserted-by":"crossref","first-page":"2288","DOI":"10.1167\/iovs.12-11082","article-title":"Homocysteine inhibition of endothelium-dependent nitric oxide-mediated dilation of porcine retinal arterioles via enhanced superoxide production","volume":"54","author":"Omae","year":"2013","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.dsx.2021.102355_bib35","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1046\/j.1440-1681.1999.03133.x","article-title":"Effect of homocysteine on the production of nitric oxide in endothelial cells","volume":"26","author":"Chow","year":"1999","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"10.1016\/j.dsx.2021.102355_bib36","doi-asserted-by":"crossref","first-page":"27","DOI":"10.2174\/1389200052997357","article-title":"Mechanisms of increased vascular oxidant stress in hyperhomocys-teinemia and its impact on endothelial function","volume":"6","author":"Weiss","year":"2005","journal-title":"Curr Drug Metabol"},{"key":"10.1016\/j.dsx.2021.102355_bib37","doi-asserted-by":"crossref","first-page":"2717","DOI":"10.1161\/01.CIR.103.22.2717","article-title":"Homocysteine induces expression and secretion of monocyte chemoattractant protein-1 and interleukin-8 in human aortic endothelial cells","volume":"103","author":"Poddar","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.dsx.2021.102355_bib38","doi-asserted-by":"crossref","first-page":"5515","DOI":"10.1167\/iovs.10-6870","article-title":"The role of N-methyl-D-aspartate receptor activation in homocysteine-induced death of retinal ganglion cells","volume":"52","author":"Ganapathy","year":"2011","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.dsx.2021.102355_bib39","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1159\/000471813","article-title":"Folic acid and homocysteine in chronic kidney disease and cardiovascular disease progression: which comes first?","volume":"7","author":"Cianciolo","year":"2017","journal-title":"Cardiorenal Med"},{"key":"10.1016\/j.dsx.2021.102355_bib40","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1161\/01.CIR.0000027586.64231.1B","article-title":"Effect of hyperhomocysteinemia on plasma or tissue adenosine levels and renal function","volume":"106","author":"Chen","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.dsx.2021.102355_bib41","doi-asserted-by":"crossref","first-page":"305","DOI":"10.5414\/CN107296","article-title":"Relation of homocysteine to early nephropathy in patients with type 2 diabetes","volume":"77","author":"Li","year":"2012","journal-title":"Clin Nephrol"},{"key":"10.1016\/j.dsx.2021.102355_bib42","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1515\/CCLM.1998.032","article-title":"The increase of plasma homocysteine concentrations with age is partly due to the deterioration of renal function as determined by plasma cystatin C","volume":"36","author":"Norlund","year":"1998","journal-title":"Clin Chem Lab Med"},{"key":"10.1016\/j.dsx.2021.102355_bib43","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1046\/j.1523-1755.1999.0550031028.x","article-title":"Plasma total homocysteine and cysteine in relation to glomerular filtration rate in diabetes mellitus","volume":"55","author":"Wollesen","year":"1999","journal-title":"Kidney Int"},{"key":"10.1016\/j.dsx.2021.102355_bib44","first-page":"92","article-title":"Homocysteine concentrations lowered following dietary intervention in an aboriginal community","volume":"12","author":"Rowley","year":"2003","journal-title":"Asia Pac J Clin Nutr"},{"key":"10.1016\/j.dsx.2021.102355_bib45","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.2147\/OPTH.S46718","article-title":"Intervention with vitamins in patients with nonproliferative diabetic retinopathy: a pilot study","volume":"7","author":"Smolek","year":"2013","journal-title":"Clin Ophthalmol"}],"container-title":["Diabetes & Metabolic Syndrome: Clinical Research & Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1871402121003751?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1871402121003751?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T09:15:01Z","timestamp":1761729301000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1871402121003751"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":45,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,1]]}},"alternative-id":["S1871402121003751"],"URL":"https:\/\/doi.org\/10.1016\/j.dsx.2021.102355","relation":{},"ISSN":["1871-4021"],"issn-type":[{"value":"1871-4021","type":"print"}],"subject":[],"published":{"date-parts":[[2022,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Plasma homocysteine is associated with nonproliferative retinopathy in patients with type 2 diabetes without renal disease","name":"articletitle","label":"Article Title"},{"value":"Diabetes & Metabolic Syndrome: Clinical Research & Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.dsx.2021.102355","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Diabetes India. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"102355"}}